Biotech News

LeMaitre to Participate in Upcoming Investor Conferences

LeMaitre Vascular (LMAT)LeMaitre VascularConference / presentation

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.

Jefferies London Healthcare Conference 2025

Tuesday, November 18, 2025 Waldorf Hilton, London Dorian LeBlanc, CFO, will present at 8:00 AM GMT

Wolfe Research 7th Annual Healthcare Conference

Wednesday, November 19, 2025 Wolfe NYC Offices, New York, NY David Roberts, President, will present at 10:40 AM ET

Piper Sandler 37 th Annual Healthcare Conference

Thursday, December 4, 2025 Lotte Palace, New York, NY Dorian LeBlanc, CFO, will present at 3:20 PM ET

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. For more information about the Company, please visit www.lemaitre.com .

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.

Contact: Sandra Millar LeMaitre Vascular, Inc. +1-781-425-1686 [email protected]

Related news

LeMaitre Vascular

LeMaitre Vascular is a medical device company serving vascular surgeons with implants, grafts, and related products. The business is rooted in procedure-linked vascular care.

Recent company news

Stock data

Close
81.86 USD
Market cap
2.09B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States